Loading...
Linezolid for drug‐resistant pulmonary tuberculosis
BACKGROUND: Linezolid was recently re‐classified as a Group A drug by the World Health Organization (WHO) for treatment of multi‐drug resistant tuberculosis (MDR‐TB) and extensively drug‐resistant tuberculosis (XDR‐TB), suggesting that it should be included in the regimen for all patients unless con...
Na minha lista:
| Udgivet i: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley & Sons, Ltd
2019
|
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6426281/ https://ncbi.nlm.nih.gov/pubmed/30893466 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012836.pub2 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|